MedTrace Logo

High-Flow Nasal Cannula in Severe COVID-19 With Acute Hypoxemic Respiratory Failure.

NCT04609462 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 199

Last updated 2021-04-01

No results posted yet for this study

Summary

This open label randomized controlled multicenter phase II trial will evaluate the clinical impact of the use of HFNC vs. conventional oxygen therapy in patients with moderate and severe hypoxemic acute respiratory failure secondary to SARS-CoV-2 infection.

Conditions

  • Covid19
  • Acute Hypoxemic Respiratory Failure

Interventions

PROCEDURE

Conventional oxygen therapy

Oxygen therapy by conventional nasal cannula / prongs, venturi mask, or mask with reservoir

PROCEDURE

High flow nasal cannula

Breathing support with High-flow nasal cannula

Sponsors & Collaborators

  • Fundacion Clinica Valle del Lili

    lead OTHER

Principal Investigators

  • Gustavo A. Ospina Tascón, MDPhD · Fundacion Clinica Valle del Lili

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-08-11
Primary Completion
2021-01-13
Completion
2021-02-10

Countries

  • Colombia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04609462 on ClinicalTrials.gov